{
    "organizations": [],
    "uuid": "b92493ef57a7ce6a657d388a07eec674ac2881e2",
    "author": "",
    "url": "https://uk.reuters.com/article/us-pfizer-results/pfizers-quarterly-profit-rises-14-percent-idUKKBN1I23EI",
    "ord_in_thread": 0,
    "title": "Pfizer's quarterly profit rises 14 percent",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 1, 2018 / 10:54 AM / Updated 22 minutes ago Pfizer tops profit estimates, driven by Prevnar sales Reuters Staff 1 Min Read\n(Reuters) - Pfizer Inc’s ( PFE.N ) quarterly profit topped Wall Street forecasts, driven by stronger-than-expected sales of pneumonia vaccine Prevnar. FILE PHOTO: The Pfizer logo is seen at their world headquarters in New York April 28, 2014. REUTERS/Andrew Kelly/File Photo\nThe largest U.S. drugmaker said on Tuesday Prevnar recorded sales of $1.38 billion in the first quarter of 2018. Analysts on average had expected sales of $1.37 billion, according to Thomson Reuters I/B/E/S.\nPfizer’s net profit rose to $3.56 billion or 59 cents per share, from $3.12 billion or 51 cents per share a year earlier.\nExcluding one-time items, the company earned 77 cents per share, topping estimates of 74 cents, according to Thomson Reuters I/B/E/S.\nTotal revenue rose 1 percent to $12.91 billion. Analysts had expected $13.13 billion.\nPfizer shares fell 0.9 percent to $36.28 in premarket trading on Tuesday. Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Sai Sachin Ravikumar",
    "published": "2018-05-01T13:56:00.000+03:00",
    "crawled": "2018-05-01T14:26:22.033+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "updated",
        "minute",
        "ago",
        "pfizer",
        "top",
        "profit",
        "estimate",
        "driven",
        "prevnar",
        "sale",
        "reuters",
        "staff",
        "min",
        "read",
        "reuters",
        "pfizer",
        "inc",
        "quarterly",
        "profit",
        "topped",
        "wall",
        "street",
        "forecast",
        "driven",
        "sale",
        "pneumonia",
        "vaccine",
        "prevnar",
        "file",
        "photo",
        "pfizer",
        "logo",
        "seen",
        "world",
        "headquarters",
        "new",
        "york",
        "april",
        "photo",
        "largest",
        "drugmaker",
        "said",
        "tuesday",
        "prevnar",
        "recorded",
        "sale",
        "billion",
        "first",
        "quarter",
        "analyst",
        "average",
        "expected",
        "sale",
        "billion",
        "according",
        "thomson",
        "reuters",
        "pfizer",
        "net",
        "profit",
        "rose",
        "billion",
        "cent",
        "per",
        "share",
        "billion",
        "cent",
        "per",
        "share",
        "year",
        "earlier",
        "excluding",
        "item",
        "company",
        "earned",
        "cent",
        "per",
        "share",
        "topping",
        "estimate",
        "cent",
        "according",
        "thomson",
        "reuters",
        "total",
        "revenue",
        "rose",
        "percent",
        "billion",
        "analyst",
        "expected",
        "billion",
        "pfizer",
        "share",
        "fell",
        "percent",
        "premarket",
        "trading",
        "tuesday",
        "reporting",
        "akankshita",
        "mukhopadhyay",
        "bengaluru",
        "editing",
        "sai",
        "sachin",
        "ravikumar"
    ]
}